The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
Liraglutide improved hepatic steatosis and metabolic parameters, not LS, in patients with MASLD, though its effect on LS was limited. These findings support the favorable influence of liraglutide on MASLD management.
Authors
- Dong Yun Kim (ORCID: https://orcid.org/0000-0002-2471-3385)
- Julie So (ORCID: https://orcid.org/0009-0003-0545-9427)
- Jaehong Jeong (ORCID: https://orcid.org/0000-0002-7749-039X)
- Do Young Kim (ORCID: https://orcid.org/0000-0002-8327-3439)
- Mi Na Kim (ORCID: https://orcid.org/0000-0001-5381-230X)
- Beom Kyung Kim (ORCID: https://orcid.org/0000-0002-5363-2496)
- Seung Up Kim (ORCID: https://orcid.org/0000-0002-9658-8050)
- Jae Seung Lee (ORCID: https://orcid.org/0000-0002-2371-0967)
- Hye Won Lee (ORCID: https://orcid.org/0000-0002-3552-3560)
- J. S. Hong
- Jun Yong Park
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1111/jgh.70134
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35